Genomics could hold the key to stroke risk, U of A researchers say
A team of University of Alberta researchers has been granted $4.79 million over four years to better understand…
Building a Clinical Trial Framework to Study GLP-1 RAs in Stroke-Related Conditions: Dennis Rivet, MD
WATCH TIME: 3 minutes “A retrospective database paper is one thing—it’s a signal. But many patients already have…
In vitro evidence of bubble-induced acoustic softening and Sanal flow choking in cardiovascular decompression
This pilot in vitro study explored how decompression-induced microbubble nucleation and acoustic softening contribute to flow instability and…
Soluble CD83 Levels Reduced in NMOSD and Relapsing MOGAD, Pointing to Potential Biomarker
Ariel Rechtman (Credit: LinkedIn) Newly published findings in Frontiers in Immunology showed lower soluble CD83 (sCD83) levels in…
Integrated molecular and detailed anatomical profiling identifies a prognostically adverse subtype of posterior fossa meningiomas: high-risk copy number alterations are associated with midline predilection and predict poor prognosis | Acta Neuropathologica Communications
Patient characteristics The patient characteristics are summarized in a table (Table 1). Among the 132 patients included in this…
Alzheimer Psychosis Agent ACP-204 Shows No Impact on Corrected QT Intervals in Phase 1 Analysis
An analysis of healthy adult participants from a phase 1 trial showed that treatment with ACP-204 (Acadia Pharmaceuticals),…
Uncovering the secrets of ‘SuperAgers’ and cognitive longevity
For 25 years, scientists at Northwestern Medicine have been studying individuals aged 80 and older – dubbed “SuperAgers”…
Cycling Boosts Brain Function in Parkinson’s Disease
Key Questions Answered Q: How does exercise help Parkinson’s patients at the brain level?A: Long-term cycling regimens appear…
Findings From First Cohort of SPG302 in Phase 2 Alzheimer Disease Trial: Sharron Gargosky, PhD
WATCH TIME: 6 minutes “I think the implications [of these findings with SPG302] for patients are incredible. This…
Signs of MS Emerge 15 Years Before Diagnosis
Key Questions Answered Q: How early can signs of multiple sclerosis appear?A: The study found increased healthcare usage…
Elecsys pTau181 Blood Test Gains European Approval for Alzheimer Disease Diagnosis
According to a new announcement, Roche’s Elecsys pTau181 test, a blood test geared to rule out Alzheimer disease…
Phase 2 Trial of Posdinemab Reveals Racial Differences in Screen Failure for Early Alzheimer Disease
Janice Wong, lead author and senior medical leader in neuroscience at Johnson & Johnson Preliminary data from the…